This multicenter retrospective study was implemented to examine the factors related to recurrence or refractoriness of CRS in the Japanese population from 2011 to 2012. ‘Recurrent’ CRS was defined as CRS that presented recurring nasal polyps or sinusitis (nasal symptoms) after ESS. ‘Refractory’ CRS was defined as recurrent CRS that was not cured by any medical treatment after ESS. This study was conducted in 15 institutions of Japan and related facilities participating in the grants‐in‐aid program (Ministry of Health, Labour and Welfare Grant; Japan Epidemiological Survey of Refractory Eosinophilic Chronic Rhinosinusitis [JESREC] Study). The study was approved by the ethics committee of each institution participating in the JESREC Study.
We assessed patients with CRS (including CRSwNP and CRSsNP) treated with ESS from January 2007 to December 2009 in the 15 institutions. The diagnosis of sinus disease was based on patient history, clinical examination, nasal endoscopy, and computed tomography (CT) of the sinuses, according to the guidelines of the European Position Paper on Rhinosinusitis and Nasal Polyps1 . Our study excluded patients treated with systemic or topical corticosteroids before surgery, patients whose information on systemic or topical corticosteroids was unknown, patients who were followed up for <28 days after surgery, patients whose white blood cell counts were 10 000/μl or more, as well as patients from which there was no pathological specimen.
Preoperative demographic and medical history including sex, age, age of onset, reaction to drugs, history of smoking, complications, and drug allergies were obtained from each patient. Rhinology specialists assessed all participants on seven symptoms and signs before surgery: nasal polyps, viscous rhinorrhea, postnasal drip, facial pain, hyposmia, anosmia, and closure of the olfactory cleft. Blood samples were taken to perform complete blood counts and measure 10 types of antigen‐specific IgE. CT findings were graded according to the Lund–MacKay method13 . Recurrence of CRS was defined as the presence of nasal polyps or nasal symptoms in nasal endoscopy.
We assessed patients with CRS (including CRSwNP and CRSsNP) treated with ESS from January 2007 to December 2009 in the 15 institutions. The diagnosis of sinus disease was based on patient history, clinical examination, nasal endoscopy, and computed tomography (CT) of the sinuses, according to the guidelines of the European Position Paper on Rhinosinusitis and Nasal Polyps
Preoperative demographic and medical history including sex, age, age of onset, reaction to drugs, history of smoking, complications, and drug allergies were obtained from each patient. Rhinology specialists assessed all participants on seven symptoms and signs before surgery: nasal polyps, viscous rhinorrhea, postnasal drip, facial pain, hyposmia, anosmia, and closure of the olfactory cleft. Blood samples were taken to perform complete blood counts and measure 10 types of antigen‐specific IgE. CT findings were graded according to the Lund–MacKay method